Glaucoma management has traditionally been focused on medical therapy as initial treatment with intensification until maximum tolerated medical therapy (MTMT) is reached. Often patients end up taking multiple eyedrops several times a day, which can sometimes lead to issues with side effects and adverse events, poor adherence, inconvenience and reduction in quality-of-life measures.
Sign up to keep reading
Create a free Member account at NZ Optics to read this article and more.
- Read all Member articles
- Full digital magazine archive
- Early access to new articles
